🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An evaluation of LY007 cell injection for recurrent/refractory CD20 was pos...
Status
Unknown
Location
Ruijin hospital
Start Date
2021-12-25
Trial ID
NCT06364852
Treatments Being Tested
The purpose of this study is to assess the feasibility, safety and efficacy...
Status
Terminated
Location
Shenzhen Geno-immune Medical Institute
Start Date
2025-09-01
Trial ID
NCT07193966
Treatments Being Tested
This is a single-arm, open-label, phase I dose-escalation clinical study to...
Status
Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2025-05-22
Trial ID
NCT06880354
Treatments Being Tested
Intravenous infusion of CART cells in the treatment of solid tumors may be ...
Status
Unknown
Location
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2016-03
Trial ID
NCT02715362
Treatments Being Tested
This study is a single arm, open label, dose exploring clinical trial to ev...
Status
Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2026-04-01
Trial ID
NCT07470073
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
This study is a single-center, open-label, dose-escalation study to observe...
Status
Recruiting
Location
Ruijin Hospital Affiliated with Shanghai Jiao Tong University School of Medicine
Start Date
2023-03-30
Trial ID
NCT05759793
Treatments Being Tested
An evaluation of LY007 cell injection for recurrent/refractory CD20 was pos...
Status
Unknown
Location
Ruijin hospital
Start Date
2021-12-25
Trial ID
NCT06279611
Treatments Being Tested
The purpose of this clinical trial is to assess the feasibility, safety and...
Status
Recruiting
Location
Shenzhen Geno-Immune Medical Institute
Start Date
2026-06-01
Trial ID
NCT04637503
Treatments Being Tested
RATIONALE: Cellular adoptive immunotherapy may stimulate the immune system ...
Status
Completed
Location
Multiple Locations
Start Date
2002-02
Trial ID
NCT00730613
Treatments Being Tested